The global Closed System Transfer Devices (CSTDs) market size is expected to reach USD 5.88 Billion in 2032 and register a steady revenue CAGR of 19.7%, according to latest analysis by Emergen Research. Increasing employment of CSTDs for combating hazardous cytostatic drugs is a major factor driving market revenue growth. Various current guidelines, regulations, or recommendations, such as National Institute for Occupational Safety and Health (NIOSH) warning on preventing occupational exposures to antineoplastic as well as other hazardous drugs in healthcare settings, have strongly encouraged adoption of CSTD. Closed system transfer devices are becoming progressively more effective, compared to conventional ones, which lowers the danger of chemotherapeutic exposure. International Society of Oncology Pharmacy Practitioners (ISOPP) claims that CSTDs are the finest, highly efficient, and preventive approach for reducing exposure to contamination during administration and preparation of cytotoxics in their guidance for proper handling of cytotoxic medications.
The report entails an organized database of the Closed System Transfer Devices Market dynamics that helps market analysts estimate the global market growth rate over the projected timeline. Therefore, the report, published by Emergen Research, is a detail-oriented compilation of the crucial aspects of the Closed System Transfer Devices Market, including the key players’ product offerings, the wide application range of these products, the major market segments, leading market contenders, their company profiles, pricing strategies, production capacities, revenue generation schemes, technological advancements, and many others
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1703
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Closed System Transfer Devices market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
BD, ICU Medical, EQUASHIELD, B. Braun SE, Baxter, Simplivia, Corvida Medical, Yukon Medical, LLC., CODAN Companies, and Caragen Ltd
Emergen Research has segmented the global Closed System Transfer Devices market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
-
Closing Mechanism Outlook (Revenue, USD Billion; 2019–2032)
- Luer-Lock Systems
- Push-To-Turn Systems
- Click-To-Lock Systems
- Color-To-Color Alignment Systems
-
Type Outlook (Revenue, USD Billion; 2019–2032)
- Membrane-To-Membrane Systems
- Needleless Systems
-
Component Outlook (Revenue, USD Billion; 2019–2032)
- Vial Access Devices
- Syringe Safety Devices
- Bag/Line Access Devices
- Accessories
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
- Analysis and estimation of the Closed System Transfer Devices Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Closed System Transfer Devices Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
